Intriguingly, PGRN messenger RNA (mRNA) levels were significantly upregulated in CD8+ T cells from tumors than that from spleen, indicating the impact of PGRN on modulating the contribution of tumor-specific CD8+ T cells (Supplementary Fig. S2A). This evidence concerns the gene CD8A and neoplasm.